口服使用的柏柏林化水基基托/氧甲基-β-环氧德克斯水凝
Bukatuka Futila Clemence1, Lin Xiao2, Guang Yang1
1Department of Biomedical Engineering, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430074, China.
Polymers
|August 29, 2024
概括
一种新型的奇托桑/碳甲基-β-环氧化水凝有效地通过口服提供柏柏林化. 这种配方增强了溶解性,提供持续释放,并表现出抗菌性质,没有观察到细胞毒性.
科学领域:
- 生物材料科学 生物材料科学
- 药物输送系统 药物输送系统
- 纳米技术 纳米技术
背景情况:
- 柏柏林化物 (BBH) 具有治疗潜力,但其口服生物可用性和溶解性不佳.
- 需要有效的口服输送系统来利用BBH的好处.
- 奇托 (CS) 和碳氧甲基-β-环氧 (CMCD) 是具有水凝形成潜力的生物相容聚合物.
研究的目的:
- 为了合成和描述一种新的口服水凝配方,用于甲酸 (BBH) 输送.
- 评估开发的水凝的可溶性,药物释放特征,抗菌活性和细胞毒性.
- 评估CS/CMCD/BBH水凝对于有效的口服药物输送的潜力.
主要方法:
- 基托 (CS) 和碳氧甲基-β-环极 (CMCD) 的物理交联形成水凝矩阵.
- 将柏柏林化物 (BBH) 装入合成的CS/CMCD水凝中.
- 描述水凝的物理特性,药物加载效率和体外药物释放动力学.
- 对抗*大肠杆菌*,金黄色葡萄球菌*和白虫*的抗菌活性的评估.
- 使用NIH3T3和HaCaT细胞系进行体外细胞毒性评估.
主要成果:
- 成功合成了一种装有BBH的CS/CMCD水凝复合物 (CS/CMCD/BBH).
- 水凝证明了BBH溶解度的提高和持续的药物释放概况.
- 观察到对测试的病原体 (*大肠杆菌*, *金黄色杆菌*, *C.albicans*) 有显著的抗菌活性.
- 在体外研究中没有显示对NIH3T3和HaCaT细胞的细胞毒性,表明良好的生物相容性.
结论:
- 开发的CS/CMCD/BBH水凝是一种有前途的平台,可以通过口服输送柏柏林化.
- 水凝增强了BBH的溶解性,确保持续释放,并具有抗菌性质.
- 该配方的安全性和有效性表明其在各种生物医学领域的潜在应用,这些领域需要口服BBH.
相关概念视频
Drug Delivery: Enteral Route
395
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
395
Routes of Drug Administration: Enteral
3.4K
Medications can be administered through the enteral route using liquids, capsules, or tablets.
Enteral administration involves drug administration via the mouth in two ways: orally or sublingually.
Unlike sublingually drugs, drugs that are taken orally pass through the gastrointestinal (GI) tract and get metabolized by the liver. Once metabolized, the drug is absorbed into the systemic circulation, reaching different body parts via the bloodstream. However, while passing through the stomach,...
Enteral administration involves drug administration via the mouth in two ways: orally or sublingually.
Unlike sublingually drugs, drugs that are taken orally pass through the gastrointestinal (GI) tract and get metabolized by the liver. Once metabolized, the drug is absorbed into the systemic circulation, reaching different body parts via the bloodstream. However, while passing through the stomach,...
3.4K
Cholinergic Antagonists: Pharmacokinetics
423
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
423
Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.1K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.1K


